Allink Biotherapeutics is based in Shanghai, China. It has raised $89M in total funding. Latest round: Series A.
Allink Biotherapeutics is based in Shanghai, China. Allink Biotherapeutics has raised $89M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Allink Biotherapeutics runs through 2025; nothing later has been disclosed. Investors on record include Lanchi Ventures, Yuanbio Venture Capital, Legend Capital, C&D Emerging Industry Equity Investment, Gaorong Ventures, Med-Fine Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
Round data for Allink Biotherapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026